| Title | American Journal of Clinical Oncology: Cancer Clinical Trials |
| Abbreviation | Am. J. Clin. Oncol.: Cancer Clin. Trials |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q3); Oncology (Q3) |
| h-index | 93 |
| Overall Rank/Ranking | 8155 |
| SCImago Journal Rank (SJR) | 0.696 |
| Impact Score | 1.67 |
| Publisher | Lippincott Williams and Wilkins |
| Country | United States |
| ISSN | 1537453X, 02773732 |
| Best Quartile | Q3 |
| Coverage History | 1982-2025 |
American Journal of Clinical Oncology: Cancer Clinical Trials is a journal covering the technologies/fields/categories related to Cancer Research (Q3); Oncology (Q3). It is published by Lippincott Williams and Wilkins. The overall rank of American Journal of Clinical Oncology: Cancer Clinical Trials is 8155. According to SCImago Journal Rank (SJR), this journal is ranked 0.696. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 93. The best quartile for this journal is Q3.
The ISSN of American Journal of Clinical Oncology: Cancer Clinical Trials journal is 1537453X, 02773732. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. American Journal of Clinical Oncology: Cancer Clinical Trials is cited by a total of 438 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of American Journal of Clinical Oncology: Cancer Clinical Trials is 1.67, which is computed in 2025 as per its definition. American Journal of Clinical Oncology: Cancer Clinical Trials IF is increased by a factor of 0.12 and approximate percentage change is 7.74% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of American Journal of Clinical Oncology: Cancer Clinical Trials is 1.67. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.67 |
| 2023 | 1.55 |
| 2022 | 2.51 |
| 2021 | 2.35 |
| 2020 | 2.01 |
| 2019 | 2.15 |
| 2018 | 2.77 |
| 2017 | 2.63 |
| 2016 | 2.15 |
| 2015 | 2.49 |
| 2014 | 2.47 |
American Journal of Clinical Oncology: Cancer Clinical Trials has an h-index of 93. It means 93 articles of this journal have more than 93 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of American Journal of Clinical Oncology: Cancer Clinical Trials is 1537453X, 02773732. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of American Journal of Clinical Oncology: Cancer Clinical Trials is 8155. According to SCImago Journal Rank (SJR), this journal is ranked 0.696. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.696 |
| 2023 | 0.711 |
| 2022 | 0.916 |
| 2021 | 0.795 |
| 2020 | 0.896 |
| 2019 | 1.060 |
| 2018 | 1.090 |
| 2017 | 0.973 |
| 2016 | 0.901 |
| 2015 | 0.936 |
| 2014 | 1.031 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 8155 |
| 2023 | 7315 |
| 2022 | 4849 |
| 2021 | 5791 |
| 2020 | 5173 |
| 2019 | 3936 |
| 2018 | 3825 |
| 2017 | 4529 |
| 2016 | 5057 |
| 2015 | 4858 |
| 2014 | 4157 |
American Journal of Clinical Oncology: Cancer Clinical Trials is published by Lippincott Williams and Wilkins. It's publishing house is located in United States. Coverage history of this journal is as following: 1982-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of American Journal of Clinical Oncology: Cancer Clinical Trials is Am. J. Clin. Oncol.: Cancer Clin. Trials. This abbreviation ('Am. J. Clin. Oncol.: Cancer Clin. Trials') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q3); Oncology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
American Journal of Clinical Oncology: Cancer Clinical Trials latest impact IF is 1.67. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.77 (2018) and 1.55 (2023), respectively, in the last 11 years. Moreover, its average IS is 2.25 in the previous 11 years.
The American Journal of Clinical Oncology: Cancer Clinical Trials has an SJR (SCImago Journal Rank) of 0.696, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.090 in 2018 and the lowest being 0.696 in 2024. Furthermore, the average SJR of the American Journal of Clinical Oncology: Cancer Clinical Trials over the previous 11-year period stands at 2.25.
The latest h-index of the American Journal of Clinical Oncology: Cancer Clinical Trials is 93.
The American Journal of Clinical Oncology: Cancer Clinical Trials is published by the Lippincott Williams and Wilkins, with its country of publication being the United States.
The American Journal of Clinical Oncology: Cancer Clinical Trials is currently ranked 8155 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3825 in 2018 and its lowest position of 8155 in 2024.
The standard ISO4 abbreviation for the American Journal of Clinical Oncology: Cancer Clinical Trials is Am. J. Clin. Oncol.: Cancer Clin. Trials.
American Journal of Clinical Oncology: Cancer Clinical Trials is classified as a journal that the Lippincott Williams and Wilkins publishes.
The American Journal of Clinical Oncology: Cancer Clinical Trials encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The American Journal of Clinical Oncology: Cancer Clinical Trials is assigned the following International Standard Serial Numbers (ISSN): 1537453X, 02773732.
The best quartile for the American Journal of Clinical Oncology: Cancer Clinical Trials is Q3 (2024).
The American Journal of Clinical Oncology: Cancer Clinical Trials coverage history can be summarized as follows: 1982-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9811 | Vilnius Gediminas Technical University | 55 | 2.84 |
| Zeitschrift fur Germanistische Linguistik | journal | 27452 | Walter de Gruyter GmbH | 17 | 0.29 |
| Revue Francophone des Laboratoires (discontinued) | journal | 23244 | Elsevier Masson s.r.l. | 8 | 0.00 |
| Entrepreneurship Theory and Practice | journal | 168 | SAGE Publications Ltd | 212 | 13.35 |
| Archives of Phytopathology and Plant Protection | journal | 16692 | Taylor and Francis Ltd. | 35 | 1.42 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| Journal of Sociolinguistics | journal | 4415 | Wiley-Blackwell Publishing Ltd | 68 | 2.14 |
| English Literary Renaissance | journal | 29995 | University of Chicago Press | 23 | 0.24 |
| Journal of Tissue Engineering and Regenerative Medicine | journal | 8612 | John Wiley and Sons Ltd | 95 | 3.01 |
| Revista do Colegio Brasileiro de Cirurgioes | journal | 16618 | Colegio Brasileiro de Cirurgioes | 31 | 0.94 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.67 |
| 2023 | 1.55 |
| 2022 | 2.51 |
| 2021 | 2.35 |
| 2020 | 2.01 |
| 2019 | 2.15 |
| 2018 | 2.77 |
| 2017 | 2.63 |
| 2016 | 2.15 |
| 2015 | 2.49 |
| 2014 | 2.47 |
